Global Dialysis Market Projected to Reach $141.5 Billion by 2031

The structural demand for renal replacement therapy is anchored by the growing number of patients requiring long-term care. In the United States alone, over 808,000 individuals live with end-stage renal disease, with a significant majority relying on dialysis. Favorable reimbursement policies, specifically adjustments to the ESRD Prospective Payment System by the Centers for Medicare and Medicaid Services, continue to reinforce treatment volumes across both home and in-center settings. While North America currently commands approximately 46.2% of the global market share, the Asia-Pacific region is emerging as the fastest-growing territory, supported by government-funded access programs in China and India.

Technological innovation is simultaneously altering how care is delivered. The integration of AI-assisted therapy management and cloud-connected peritoneal dialysis cyclers allows for more precise remote monitoring, reducing complications such as peritonitis. Manufacturers are also prioritizing automation, exemplified by the FDA-cleared Dialysis Full Assist System from Nikkiso. Despite the shift toward home-based care, in-center hemodialysis remains the clinical standard for patients with complex comorbidities. Major industry players including Fresenius Medical Care, Vantive, B. Braun, and Nipro Corporation are currently positioning themselves to capture the expanded demand for both consumables and advanced machine infrastructure through the next decade.